We are live on
!
Find out more
AAF
Andra AP-fonden Portfolio holdings
AUM
$8.39B
1-Year Est. Return
21.19%
This Fund
S&P 500
This Quarter
Est. Return
-0.07%
1 Year Est. Return
+21.19%
3 Year Est. Return
+70.53%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.86B
AUM Growth
-$38.5M
(-0.79%)
Cap. Flow
+$72.4M
Cap. Flow
% of AUM
1.49%
Top 10 Holdings %
Top 10 Hldgs %
4.3%
Holding
618
New
24
Increased
289
Reduced
263
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$19.3M |
| 2 |
Bath & Body Works
BBWI
|
+$11.5M |
| 3 |
Chubb
CB
|
+$10.8M |
| 4 |
Upstart Holdings
UPST
|
+$10.5M |
| 5 |
AbbVie
ABBV
|
+$9.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$22M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$13.1M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$7.48M |
| 4 |
Reinsurance Group of America
RGA
|
+$7.02M |
| 5 |
XPO
XPO
|
+$6.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.83% |
| 2 | Healthcare | 16.68% |
| 3 | Financials | 13.87% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Industrials | 11.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gartner
IT
$11.1B
| $23.4M | 0.48% |
77,100
+7,000
| +10% | +$2.03M |
|
2
Robert Half
RHI
$4.14B
| $22.8M | 0.47% |
227,400
+30,700
| +16% | +$3.01M |
|
3
Waters Corp
WAT
$37.5B
| $22.6M | 0.46% |
63,200
+2,800
| +5% | +$1.1M |
|
4
Agilent Technologies
A
$39.5B
| $21.3M | 0.44% |
134,900
+22,200
| +20% | +$3.59M |
|
5
Fortinet
FTNT
$108B
| $20.6M | 0.42% |
352,500
+27,500
| +8% | +$1.59M |
|
6
Target
TGT
$66.7B
| $20.2M | 0.42% |
88,300
-5,500
| -6% | -$1.38M |
|
7
eBay
EBAY
$51.4B
| $19.6M | 0.4% |
281,700
+42,400
| +18% | +$3.04M |
|
8
ResMed
RMD
$30.9B
| $19.6M | 0.4% |
74,400
-900
| -1% | -$246K |
|
9
Adobe
ADBE
$105B
| $19.6M | 0.4% |
34,000
+3,400
| +11% | +$2.14M |
|
|
10
Analog Devices
ADI
$174B
| $19.3M | 0.4% |
+115,031
| New | +$19.3M |
|
11
EPAM Systems
EPAM
$5.57B
| $19.2M | 0.39% |
33,600
+2,200
| +7% | +$1.29M |
|
12
Accenture
ACN
$106B
| $18.9M | 0.39% |
59,100
+400
| +0.7% | +$130K |
|
|
IPG
13
DELISTED
Interpublic Group of Companies
IPG
| $18.7M | 0.39% |
511,200
+9,500
| +2% | +$340K |
|
14
Expeditors International
EXPD
$22.2B
| $18.6M | 0.38% |
156,300
+8,300
| +6% | +$1.04M |
|
15
Prologis
PLD
$136B
| $18.5M | 0.38% |
147,600
+13,700
| +10% | +$1.78M |
|
16
Idexx Laboratories
IDXX
$45B
| $18.2M | 0.38% |
29,300
+1,200
| +4% | +$806K |
|
17
Biogen
BIIB
$30.9B
| $18M | 0.37% |
63,500
+4,400
| +7% | +$1.44M |
|
18
HCA Healthcare
HCA
$91.4B
| $17.9M | 0.37% |
73,800
+5,100
| +7% | +$1.25M |
|
19
Paychex
PAYX
$43.9B
| $17.9M | 0.37% |
159,200
+25,300
| +19% | +$2.84M |
|
20
PayPal
PYPL
$50.6B
| $17.4M | 0.36% |
67,000
+9,000
| +16% | +$2.55M |
|
21
Pentair
PNR
$10.7B
| $17.3M | 0.36% |
238,100
+19,900
| +9% | +$1.48M |
|
22
W.W. Grainger
GWW
$64.5B
| $17.1M | 0.35% |
43,400
+1,000
| +2% | +$434K |
|
|
23
Upstart Holdings
UPST
$2.58B
| $16.9M | 0.35% |
+53,451
| New | +$10.5M |
|
24
JD.com
JD
$43.4B
| $16.9M | 0.35% |
234,000
-20,100
| -8% | -$1.48M |
|
25
Johnson & Johnson
JNJ
$644B
| $16.8M | 0.35% |
104,300
+8,800
| +9% | +$1.5M |
|
Similar funds
NW
QC
VA
MWM
GGHC
FT
DM
GRQ
Andra AP-fonden's Q3 2021 Portfolio in Review
As of Q3 2021, Andra AP-fonden held 618 positions worth $4.86B, down 0.79% from $4.9B the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.
Andra AP-fonden's Q3 2021 filing shows 24 new, 289 increased, 263 reduced and 21 closed positions. Its largest new stake was Analog Devices: 115,031 shares worth $19.3M. The largest sale was Alexion Pharmaceuticals, an estimated $22M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Andra AP-fonden's largest Q3 2021 buy was Analog Devices: 115,031 shares worth $19.3M.
- Andra AP-fonden added most to Otis Worldwide in Q3 2021, an estimated $4.8M increase.
- Andra AP-fonden's biggest Q3 2021 reduction was Jazz Pharmaceuticals, cutting an estimated $5.36M.
- Andra AP-fonden fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22M.
- Andra AP-fonden's ten largest holdings make up 4.3% of its $4.86B portfolio in Q3 2021.
- Andra AP-fonden opened 24 new positions and closed 21 in Q3 2021.
- Andra AP-fonden's portfolio value fell 0.79% quarter-over-quarter to $4.86B.
Based on Andra AP-fonden's 13F filing for Q3 2021, filed 12 Nov 2021.